BetterLife Pharma Files $100M Public Offering Prospectus

BetterLife Pharma has filed a prospectus for a public offering aimed at raising $100 million. This funding is intended for ongoing research and development of its product pipeline. The public offering will allow the company to enhance its capital structure and potentially drive future growth in the market. For investors, this offering can be significant as it reflects BetterLife’s strategic focus on advancing its business objectives and supporting expansion efforts.